| 摘要 |
<p>The present invention relates to the use of a compound of Formula (I<SUP>IV</SUP>) or pharmaceutically acceptable salt or solvate, isomer or prodrug thereof in the manufacturing of a medicament for the treatment and/or prophylaxis of any of the diseases selected from the group consisting of macular degeneration, corneal neovascularization or angiogenesis, iris neovascularization or angiogenesis, retinal neovascularization or angiogenesis, diabetic proliferative retinopathy and non- diabetic proliferative retinopathy.</p> |
| 申请人 |
ACTION MEDICINES, S.L.;CUEVAS SANCHEZ, PEDRO;GIMENEZ GALLEGO, GUILLERMO;SAENZ DE TEJADA GORMAN, INIGO;ANGULO FRUTOS, JAVIER;LOZANO PUERTO, ROSA MARIA;ROMERO GARRIDO, ANTONIO;VALVERDE LOPEZ, SERAFIN |
发明人 |
CUEVAS SANCHEZ, PEDRO;GIMENEZ GALLEGO, GUILLERMO;SAENZ DE TEJADA GORMAN, INIGO;ANGULO FRUTOS, JAVIER;LOZANO PUERTO, ROSA MARIA;ROMERO GARRIDO, ANTONIO;VALVERDE LOPEZ, SERAFIN |
